Medexus Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA58410Q2036
CAD
2.74
0.06 (2.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1112615,
    "name": "Medexus Pharmaceuticals, Inc.",
    "stock_name": "Medexus Pharmaceuticals, Inc.",
    "full_name": "Medexus Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/medexus-pharmaceuticals-inc",
    "exchange": 30,
    "exchangecode": "TSE",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "2.74",
    "chg": 0.06,
    "chgp": "2.24%",
    "dir": 1,
    "prev_price": "2.68",
    "mcapval": "92.28",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA58410Q2036",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "71.14 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medexus-pharmaceuticals-inc-1112615-30&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medexus Pharmaceuticals Adjusts Valuation Amid Mixed Technical Indicators and Market Outlook",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medexus-pharmaceuticals-downgraded-to-strong-sell-amid-valuation-decline-and-technical-weakness-3626432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MedexusPharmace_mojoScore_3626432.png",
        "date": "2025-10-16 17:15:01",
        "description": "Medexus Pharmaceuticals, Inc. has undergone a recent evaluation adjustment, shifting its valuation grade from very expensive to fair. This change reflects updated financial metrics and technical indicators, indicating a reassessment of the stock's standing within the competitive pharmaceutical sector. The company's financial ratios provide further insights into its structure."
      }
    ],
    "total": 1,
    "sid": "1112615",
    "stock_news_url": "https://www.marketsmojo.com/news/medexus-pharmaceuticals-inc-1112615"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available